# Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

> **NCT00324259** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 66 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Estradiol

## Key facts

- **NCT ID:** NCT00324259
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2011-03
- **Final completion:** 2014-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324259, "Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00324259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*